Endoc Biotech planning to set up Pharmaceutical Project in Gujarat

Endoc Biotech Private Limited intends to establish a new Active Pharmaceutical Ingredients (API) manufacturing facility in Jhiyana, Rajkot, Gujarat. The project, which is scheduled to be completed in 2025, will generate a variety of APIs for both domestic and foreign markets. The project's budget is 12 crores. Endoc Biotech has made a considerable investment in the initiative, which will enable the company increase its API manufacturing capacity. In Gujarat, the corporation now operates two API manufacturing facilities, one in Khijadiya and the other in Dahej. 

The new API manufacturing facility in Jhiyana will be the company's third in Gujarat. The project is also projected to generate jobs in the surrounding area. Endoc Biotech has claimed that it intends to employ more than 1,000 people for the new plant. The project is still in the planning stages, and Endoc Biotech has not yet provided any precise specifics about the APIs that it intends to manufacture at the new facility. However, the company has said that it would concentrate on providing high-value, in-demand APIs. 

The project is a step forward for the Indian pharmaceutical industry. India is a significant supplier of APIs, and the new Jhiyana facility will contribute to India's status as a global leader in API manufacture. Potential benefits of the project The new API project at Jhiyana, Rajkot, Gujarat is expected to have a number of benefits for the region and for the Indian pharmaceutical industry as a whole. Economic benefits: The project is a significant investment for Endoc Biotech and is expected to create over 1,000 jobs in the region. This will boost the local economy and provide employment opportunities for people in the area. Industrial benefits: The new facility will help to strengthen India's position as a global leader in API manufacturing. India is a major exporter of APIs and the new facility will help to increase India's export capacity. Healthcare benefits: The new facility will produce a range of APIs for both domestic and international markets. This will help to improve the availability of affordable medicines in India and around the world.Conclusion The new API project at Jhiyana, Rajkot, Gujarat is a positive development for the region and for the Indian pharmaceutical industry as a whole. The project is expected to have a number of economic, industrial, and healthcare benefits.

As of September 2023, The project is currently in the stage of being approved currently awaiting approval from the government.

News by Rahul Yeligetti